Article
Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
20 Apr 2018
Abstract excerpt
// Satoshi Ogura 1, * , Yuichi Yoshida 1, * , Tomohide Kurahashi 1 , Mayumi Egawa 1 , Kunimaro Furuta 1 , Shinichi Kiso 1 , Yoshihiro Kamada 1, 2 , Hayato Hikita 1 , Hidetoshi Eguchi 3 , Hisakazu Ogita 4 , Yuichiro Doki 3 , Masaki Mori 3 , Tomohide Tatsumi 1 and Tetsuo Takehara 1 1 Department of Gastroenterology and Hepatology, Osaka University, Graduate School of Medicine, Suita, Osaka, Japan 2 Department of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
